CAS 156223-05-1 Nootropic Powder 3-(2,4-dimethoxybenzylidene)anabaseine

Place of Origin China
Brand Name XRD
Certification GMP
Model Number 156223-05-1
Minimum Order Quantity negotiable
Price Inquiry for Negotiable
Packaging Details 1-2 kg / aluminum foil bag, 25kg/ drum, as required
Delivery Time 1-2days after payment received
Payment Terms T/T bank, Western Union, Bitcoin, Etc
Supply Ability 100KG/ Month

Contact me for free samples and coupons.

Whatsapp:0086 18588475571

Wechat: 0086 18588475571

Skype: sales10@aixton.com

If you have any concern, we provide 24-hour online help.

x
Product Details
CAS 156223-05-1 Product Name GTS-21
Type Pharmaceutical Raw Materials Appearance White Powder
Usage For Nootropics Alias GTS 21 2HCl(DMXBA)
Assay 99% Key Words GTS 21
High Light

brain nootropics

,

memory enhancing supplements

Leave a Message
Product Description

 

99% 3-(2,4-dimethoxybenzylidene)anabaseine Manufacturer CAS 156223-05-1

 

Details :

 

Chemical name 3-[(3E)-3-[(2,4-dimethoxyphenyl)methylidene]-5,6-dihydro-4H-pyridin-2-yl]pyridine

Synonyms 3-(2,4-dimethoxy-benzylidene)anabaseine
Other name:DMBX-A
Cas: 156223-05-1
MF:C19H20N2O2
MW:308.374
Appearance: White powder
Purity:99%

GTS-21 (DMBX-A) is a derivative of the natural product anabaseine that acts as a partial agonist at neural nicotinic acetylcholine receptors. It binds to both the α4β2 and α7 subtypes, but activates only the α7 to any significant extent

Both GTS-21 itself and its demethylated active metabolite 4-OH-GTS-21 display nootropic and
neuroprotective effects, and GTS-21 is being investigated for the treatment ofAlzheimer's disease,
nicotine dependence,and, most significantly, for schizophrenia.
GTS-21 (DMXB-A) is being investigated for the treatment of Alzheimer's disease,nicotine dependence

 

CAS 156223-05-1 Nootropic Powder 3-(2,4-dimethoxybenzylidene)anabaseine 0

 

99% 3-(2,4-dimethoxybenzylidene)anabaseine Manufacturer CAS 156223-05-1